Management of Yellowing Epidermis Graft Site
Immediate Assessment and Action
- The British Journal of Dermatology recommends obtaining bacterial and fungal cultures immediately from the yellowing areas, as yellow discoloration typically represents either purulent exudate from infection or sloughy necrotic tissue 1, 2, 3
- Take swabs from the yellowing/sloughy areas for bacterial and candidal culture, and assess for clinical signs of infection including extension of graft loss, wound conversion, delayed healing, or systemic signs 1, 2, 3, 4
- Document the percentage of graft affected and whether there is subepidermal pus formation 1, 3
Management Algorithm
- Apply topical antimicrobial agents to the yellowing/sloughy areas only, with choice guided by local microbiological advice and culture results 1, 2, 3, 4
- Consider silver-containing products or dressings as first-line topical antimicrobials 1, 2, 3, 4
- Administer systemic antibiotics only if there are clinical signs of systemic infection - do not use prophylactically 1, 2, 3, 4
Dressing Management
- Apply nonadherent dressings to any exposed dermis following debridement or graft loss 1, 2, 3, 4
- Use atraumatic, nonadherent dressings such as Mepitel™ or Telfa™ as primary layer 1, 2, 3, 4
- Apply secondary foam or absorptive burn dressing to collect exudate 1, 2, 3, 4, 5
Critical Pitfalls to Avoid
- Do not leave infected or necrotic tissue in place - while detached epidermis can sometimes act as a biological dressing in acute settings, yellowing indicates this tissue is no longer viable and is likely harboring infection 1, 2, 3, 4
- Do not initiate systemic antibiotics without clear clinical signs of infection - this promotes resistance and does not improve outcomes in the absence of systemic involvement 1, 2, 3, 4